Skip to content

Clinical trials

Phase 1 Leukemia, Myeloid, Chronic-Phase trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Phase 1 Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20015
20026
20035
20044
20055
20062
20073
20084
20093
20112
20122
20133
20151
20161
20172
20181
20191
20201
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Terminated9
Recruiting4
Unknown status3
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
M.D. Anderson Cancer Center7
City of Hope Medical Center4
Memorial Sloan Kettering Cancer Center4
Jonsson Comprehensive Cancer Center3
Northwestern University3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
University of California, San Francisco3
Barbara Ann Karmanos Cancer Institute2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase74
Leukemia, Myeloid, Accelerated Phase51
Precursor Cell Lymphoblastic Leukemia-Lymphoma50
Blast Crisis44
Leukemia, Lymphocytic, Chronic, B-Cell44
Leukemia42
Hodgkin Disease41
Leukemia, Myeloid, Acute41
Lymphoma, Large B-Cell, Diffuse40
Lymphoma, Mantle-Cell40

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.